换一批
换一批Predictive factors for outcome and response in patients treated with second-generation tyrosine kinase inhibitors for chronic myeloid leukemia in chronic phase after imatinib failure.
作者：
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药(Antineoplastic Agents);苯甲酰胺类(Benzamides);细胞遗传学分析(Cytogenetic Analysis);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);白血病, 髓样, 慢性期(Leukemia, Myeloid, Chronic-Phase);男(雄)性(Male);中年人(Middle Aged);哌嗪类(Piperazines);预后(Prognosis);蛋白激酶抑制剂(Protein Kinase Inhibitors);蛋白酪氨酸激酶类(Protein-Tyrosine Kinases);嘧啶类(Pyrimidines);噻唑类(Thiazoles);治疗失败(Treatment Failure);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.1182/blood-2010-07-293977
PMID
21030554
发布时间
2023-02-02
- 浏览23
Blood
1822-7页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
